UVA receives training grant for new kidney disease researchers

December 15, 2006

Charlottesville, Va., Dec. 15, 2006 - Kidney disease is a rapidly growing health problem in the United States, with more than 20 million people suffering from some chronic form of the disease. Additionally, approximately 400,000 patients in the U.S. undergo regular kidney dialysis or have undergone kidney transplantation.

While the number of people with kidney disease continues to increase, the number of clinicians and researchers being trained in the field isn't keeping up with demand, according to University of Virginia School of Medicine nephrologist Dr. Mark Okusa.

Dr. Okusa was recently awarded a 5-year, $583,000 NIH training grant on behalf of the Division of Nephrology to train the next generation of investigators in kidney disease research. "A major focus area in the training of new researchers and academic physicians is the ability to translate research from the lab to the bedside," Dr. Okusa says. "We have assembled a multidisciplinary team of 26 faculty mentors to train academic nephrologists and investigators to address the growing problem of kidney disease."

UVa plans to use the grant to train four researchers yearly in areas such as immunology, functional genomics, epidemiology, biostatistics and clinical investigations as they relate to kidney disease. Participating departments and centers include Medicine, Pediatrics, Pharmacology, Biochemistry and Molecular Genetics, Biomedical Engineering, Molecular Physiology and Biophysics, the Cardiovascular Research Center, Center for Cell Signaling, the Carter Immunology Center and the Specialized Center for Systemic Lupus Erythematosis

"Kidney disease hasn't received the attention that many other life-threatening conditions have over the years because our patients live quite a long time with this chronic condition and may not know it. However during this period of "silent disease" considerable damage is occurring throughout the body. The quality of life for these people after the damage is done and especially for those on dialysis, is diminished," says Dr. Okusa. "We hope these new researchers may identify why kidneys fail and how to cure or reverse kidney diseases through the development of new treatment and therapies to improve the quality of life of millions of people who suffer from kidney disease."

Nephrology is one of many specialty areas which are experiencing a shortage of physicians. Okusa says that while the number of physicians going into nephrology is barely keeping up with demand, there is no comparison to the number of physicians and scientists going into nephrology research, which is miniscule by comparison.

"If we are to meet the rapidly growing need for academic physicians and investigators, programs such as this one are vital," says R. Edward Howell, Vice President and CEO of UVA Medical Center. "Receiving one of these highly competitive grants is a testament to the integrated, multi-disciplinary training program put together by Dr. Okusa and his colleagues."
-end-


University of Virginia Health System

Related Kidney Disease Articles from Brightsurf:

Waistline matters in kidney disease
Does fat matter in kidney disease? The investigators found that all measures of higher abdominal fat content (including visceral fat, liver fat, or subcutaneous fat) and slower walk times were associated with increased levels of cardiometabolic risk factors in adults with non-dialysis dependent kidney disease.

Reducing urinary protein for patients with rare kidney disease slows kidney decline
New findings show that reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis can significantly slow declines in kidney function and extend time before patients' kidneys fail.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Acute kidney injury and end stage kidney disease in severe COVID-19
Many COVID-19 patients experience hematuria, proteinuria and elevated serum creatinine concentration early in the course of the disease.

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

A healthy diet may help prevent kidney disease
In an analysis of published studies, a healthy dietary pattern was associated with a 30% lower incidence of chronic kidney disease.

Is kidney failure a man's disease?
A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.

Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.

Read More: Kidney Disease News and Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.